Stan Wang is the founder of Thymmune Therapeutics. Thymmune Therapeutics has raised $7M in total funding. Latest round: Seed. Based in Cambridge, USA.
Stan Wang is the founder and CEO of Thymmune Therapeutics. The company raised $7 million in seed financing to develop its machine learning-enabled thymic cell engineering platform. Thymmune aims to restore normal immune function in aging and disease by developing a pipeline of therapies, including THY-100, which will advance into preclinical studies. The company utilizes an iPSC-thymic cell manufacturing approach to generate off-the-shelf cells at scale.
Full founder directory · Investor directory · Company funding database · Fundraising library